Doyle Michael MD is categorized under Family Practice Doctors in Orange, CT and active since 2003.
Doyle Michael MD was established in 2003, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Michael Doyle at the company’s single location by writing to 339 Boston Post Road # 182, Orange, Connecticut CT 06477 or by phoning (203) 799-1200. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Doyle Michael MD |
| Contact Person: | Michael Doyle |
| Address: | 339 Boston Post Road # 182, Orange, Connecticut 06477 |
| Phone Number: | (203) 799-1200 |
| Website Address: | ctfertility.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Doyle Michael MD was started in 2003 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael Doyle for inquiries that concern Doyle Michael MD by calling the company number (203) 799-1200, as your correspondence is most welcome. Additionally, the physical location of the single location of Doyle Michael MD can be found at the coordinates 41.263343,-73.005735 as well as the street address 339 Boston Post Road # 182 in Orange, Connecticut 06477.
For its online presence, you may visit Doyle Michael MD’s website at ctfertility.com and engage with its social media outlets through on Twitter and on Facebook.